| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Cartt Stephen Lahue serves as a Director at LCTX. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $171K at current prices.
The biggest single holding is LCTX (~$171K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 75,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2015 | LCTX Lineage Cell Therapeutics, Inc. | Director | Buy | 75,000 | $2.80 | $210,066.52 | +23.7% |